Merck 2020 Research Grants

Deadline: 31 August 2020
Open to: scientists all over the world
Awards: up to 500,000 EUR per year


Merck is a vibrant team of specialists in Healthcare, Life Science and Performance Materials. It shares a passion for science and for technology while discovering and developing life in all its vibrancy, from great human questions to small everyday joys. For more than 350 years, curiosity has been driving the company to deliver excellence to patients and its customers – and to imagine the future.


The Merck research grants program is open to scientists in all career stages who are affiliated with any research-based institution, university or company. Applicants submit their application for the focus topics containing non-confidential information only. You may apply for more than one focus topic. If your application is successful, you will be invited to submit a full proposal and join a deep-dive workshop with the other finalists in 2020. Submissions are accepted from scientists in all countries all over the world.


Grants of 100,000 EUR to 500,000 EUR per year for up to 3 years are availabe in the areas of:

– Drug discovery
– Bioreactor design for cultured meat
– Next generation machine learning
– Pandemic preparedness / fighting new emerging viral infectious disease

How to apply?

To submit an application, investigators must first register with our online portal. On your first visit, you will need to register (click “register” in the online form) with a valid email address. Your registration link will then be forwarded to this email address. Refer to the FAQ section for details.

Submissions will be accepted until 31 August 2020 23:59 CEST for the Drug discovery, Bioreactor design, Next generation machine learning topics. For the Pandemic preparedness topic, there is no fixed deadline, since applications will be reviewed on a rolling basis so that we are able to provide a quicker response in these challenging times.

In order to apply, please fill the application.

For more information, please visit the official web page.